c.i. 42510 has been researched along with Macular Degeneration in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Addo, EK; Bernstein, PS; Hartnett, ME | 1 |
| Asato, R; Enaida, H; Hisatomi, T; Ikeda, Y; Ishibashi, T; Murakami, Y; Notomi, S; Sakamoto, T; Sonoda, S; Takeda, A; Terasaki, H | 1 |
1 trial(s) available for c.i. 42510 and Macular Degeneration
| Article | Year |
|---|---|
The value of pre-symptomatic genetic risk assessment for age-related macular degeneration: the Moran AMD Genetic Testing Assessment (MAGENTA) study-a study protocol for a randomized controlled trial.
Topics: Carotenoids; Clinical Trials, Phase II as Topic; Dietary Supplements; Genetic Testing; Humans; Lutein; Macular Degeneration; Multicenter Studies as Topic; Prospective Studies; Randomized Controlled Trials as Topic; Risk Assessment; Rosaniline Dyes; Zeaxanthins | 2023 |
1 other study(ies) available for c.i. 42510 and Macular Degeneration
| Article | Year |
|---|---|
Dynamic increase in extracellular ATP accelerates photoreceptor cell apoptosis via ligation of P2RX7 in subretinal hemorrhage.
Topics: Adenosine Triphosphate; Animals; Apoptosis; Apoptosis Inducing Factor; Caspase 9; Choroid; Choroidal Neovascularization; Coculture Techniques; DNA Fragmentation; Humans; Macular Degeneration; Male; Mice; Mitochondria; Photoreceptor Cells; Primary Cell Culture; Purinergic P2X Receptor Antagonists; Receptors, Purinergic P2X7; Retinal Hemorrhage; Retinal Pigment Epithelium; Rosaniline Dyes; Vitreous Body | 2013 |